Construction of adenovirus vectors through Cre-lox recombination - PubMed (original) (raw)
Construction of adenovirus vectors through Cre-lox recombination
S Hardy et al. J Virol. 1997 Mar.
Abstract
Two barriers prevent adenovirus-based vectors from having wide application. One is the difficulty of making new adenoviruses, and the second is the strong immunological reaction to viral proteins. Here we describe uses of Cre-lox recombination to overcome these problems. First, we demonstrate a simple method for constructing E1-substituted adenoviruses. Second, we demonstrate a method to construct adenovirus vectors carrying recombinant genes in place of all of the viral genes, so-called gutless adenovirus vectors. The pivotal feature in each method is the use of a negatively selected adenovirus named psi5. We engineered a cis-acting selection into psi5 by flanking its packaging site with loxP sites. When psi5 was grown in cells making a high level of Cre recombinase, the packaging site was deleted by recombination and the yield of psi5 was reduced to 5% of the wild-type level. To make a new E1-substituted virus, we used psi5 as a donor virus and recombined it with a shuttle vector via a loxP site. The resulting recombinant virus has a single loxP site next to the packaging site and therefore outgrows psi5 in the presence of Cre recombinase. To make a gutless virus, we used psi5 as a helper virus. The only viral sequences included in the gutless vector are those needed in cis for its replication and packaging. We found that a loxP site next to the packaging site of the gutless virus was necessary to neutralize homologous recombination between psi5 and the gutless viruses within their packaging domains.
Similar articles
- A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
Zhou H, Zhao T, Pastore L, Nageh M, Zheng W, Rao XM, Beaudet AL. Zhou H, et al. Mol Ther. 2001 Apr;3(4):613-22. doi: 10.1006/mthe.2001.0288. Mol Ther. 2001. PMID: 11319924 - Constructing adenoviral vectors by using the circular form of the adenoviral genome cloned in a cosmid and the Cre-loxP recombination system.
Tashiro F, Niwa H, Miyazaki J. Tashiro F, et al. Hum Gene Ther. 1999 Jul 20;10(11):1845-52. doi: 10.1089/10430349950017527. Hum Gene Ther. 1999. PMID: 10446924 - Gutted adenoviral vector growth using E1/E2b/E3-deleted helper viruses.
Barjot C, Hartigan-O'Connor D, Salvatori G, Scott JM, Chamberlain JS. Barjot C, et al. J Gene Med. 2002 Sep-Oct;4(5):480-9. doi: 10.1002/jgm.305. J Gene Med. 2002. PMID: 12221641 - Gutless adenovirus: last-generation adenovirus for gene therapy.
Alba R, Bosch A, Chillon M. Alba R, et al. Gene Ther. 2005 Oct;12 Suppl 1:S18-27. doi: 10.1038/sj.gt.3302612. Gene Ther. 2005. PMID: 16231052 Review. - Helper virus-free gutless adenovirus (HF-GLAd): a new platform for gene therapy.
Liu J, Seol DW. Liu J, et al. BMB Rep. 2020 Nov;53(11):565-575. doi: 10.5483/BMBRep.2020.53.11.185. BMB Rep. 2020. PMID: 32958121 Free PMC article. Review.
Cited by
- GAPDH suppresses adenovirus-induced oxidative stress and enables a superfast production of recombinant adenovirus.
Zhao G, Zhao P, Wang Y, Zhang H, Zhu Y, Zhong J, You W, Shen G, Luo C, Mei O, Wu X, Li J, Shu Y, Wang H, Wagstaff W, Luu HH, Bi Y, Shi LL, Reid RR, He TC, Jiang L, Tang W, Fan J, Tang Z. Zhao G, et al. Genes Dis. 2024 May 31;11(6):101344. doi: 10.1016/j.gendis.2024.101344. eCollection 2024 Nov. Genes Dis. 2024. PMID: 39188753 Free PMC article. - Cancer immunotherapies: A hope for the uncurable?
Hamdan F, Cerullo V. Hamdan F, et al. Front Mol Med. 2023 Feb 17;3:1140977. doi: 10.3389/fmmed.2023.1140977. eCollection 2023. Front Mol Med. 2023. PMID: 39086690 Free PMC article. Review. - Adenovirus small E1A directs activation of Alu transcription at YAP/TEAD- and AP-1-bound enhancers through interactions with the EP400 chromatin remodeler.
Cantarella S, Vezzoli M, Carnevali D, Morselli M, Zemke NR, Montanini B, Daussy CF, Wodrich H, Teichmann M, Pellegrini M, Berk AJ, Dieci G, Ferrari R. Cantarella S, et al. Nucleic Acids Res. 2024 Sep 9;52(16):9481-9500. doi: 10.1093/nar/gkae615. Nucleic Acids Res. 2024. PMID: 39011896 Free PMC article. - Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications.
Scarsella L, Ehrke-Schulz E, Paulussen M, Thal SC, Ehrhardt A, Aydin M. Scarsella L, et al. Viruses. 2024 Feb 28;16(3):377. doi: 10.3390/v16030377. Viruses. 2024. PMID: 38543743 Free PMC article. Review. - Adenovirus E1A binding to DCAF10 targets proteasomal degradation of RUVBL1/2 AAA+ ATPases required for quaternary assembly of multiprotein machines, innate immunity, and responses to metabolic stress.
Zemke NR, Hsu E, Barshop WD, Sha J, Wohlschlegel JA, Berk AJ. Zemke NR, et al. J Virol. 2023 Dec 21;97(12):e0099323. doi: 10.1128/jvi.00993-23. Epub 2023 Nov 14. J Virol. 2023. PMID: 37962355 Free PMC article.
References
- J Mol Biol. 1967 Jun 14;26(2):365-9 - PubMed
- J Virol. 1996 Jul;70(7):4805-10 - PubMed
- J Gen Virol. 1977 Jul;36(1):59-74 - PubMed
- J Virol. 1979 Nov;32(2):623-8 - PubMed
- J Virol. 1981 Jan;37(1):171-80 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials